|
|
|
|
The Indian Pharmaceutical
Industry is having wide range of capabilities in the
complex field of drug manufacture and technology. The
country's pharmaceutical market is a US$ 7.3 billion
opportunity with the domestic retail market expected
to cross the US$ 10 billion mark in 2010 and be worth
an estimated US$ 12-13 billion in 2012.
- The Indian pharmaceutical industry ranks 4th in
terms of volume.
- In terms of value it ranks 13th and produces 20-24
% of the world's generic drugs.
- India is also one of the top five active pharmaceutical
ingredients (API) producers.
|
The Indian Pharmaceutical sector is highly
fragmented with more than 20,000 registered units. The
leading 250 pharmaceutical companies control 70% of
the market with market leader holding nearly 7% of the
market share. To accelerate growth in this sector the
Government of India allows 100% foreign investment through
the automatic route. Industrial licensing for all bulk
drugs, intermediaries and formulations has been abolished.
The number of drugs under price control has been reduced
from 74 to 28.
|
|
|
|
|